BLR-100

N/A

Report date: 2023/06/15 15:35:34
NME

Base Information

Drug NameBLR-100
Drug Alias NameBLR-100
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionFibroblast activation protein alpha antagonists
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsUrinary Bladder NeoplasmsPancreatic NeoplasmsLiver Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlr Bio LLC
China Registration ClassN/A

Develop Information

Active CompaniesBlr Bio LLC
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsPancreatic NeoplasmsLiver Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A